The Summer 2008 issue of Olswang's Life Sciences Newsletter is now out. You can access it here. Highlights include the following morsels:
If you'd like to sign up to receive these Newsletters on a regular basis, email Jeremy here and he'll see that you are added to the circulation list.
• Generics v Lundbeck, in which Lord Hoffmann sat in the Court of Appeal for England and Wales and gave the leading opinion regarding the concept of Biogen insufficiency in patent law;
• Conor v Angiotech, a House of Lords decision concerning taxol-coated coronary stents in which Lord Hoffmann also gave the leading opinion.